Published by Josh White on 5th January 2022
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it announced on Wednesday, with KYE Pharmaceuticals in Canada.
URL: http://www.digitallook.com/dl/news/story/32372220/...